Stoquity Living researchResearch LedgerSlicesMethodologyFor institutionsAbout
Stoquity Research Ledger

Revolution Medicines Inc. (RVMD)

NASDAQ: RVMD · Biological Products, (No Diagnostic Substances) · Redwood City, CA

Our rating: Positive

Call changed from Neutral to Positive at $177.65, moderate conviction, November 5, 2026.

Breaks if: The Positive call turns wrong if any lead program misses a primary endpoint in a pivotal or registration-enabling trial reported within the next 12 months — one major readout failure at this valuation would warrant a reassessment toward Cautious, as the entire equity value rests on pipeline probability rather than on earnings power that already exists. On price, if the stock falls more than 40% from today's $177.65 within 180 trading days, the market would be signaling a material repricing of clinical risk that the current thesis cannot absorb.

Key figures

Market value$34.9B
Revenue, last 12 monthsn/a
Net income, last 12 months−$1.9B
Free cash flow, last 12 months−$1.4B
Price to earningsn/a
Free cash flow yield−4.1%
Dividend yield0.0%
Operating marginn/a
Return on equity−93.6%
Beta to the S&P 5001.09
Volatility, annualized55.6%

Reported quarters

Quarter endingRevenueYear on yearEarnings per shareFree cash flow
September 30, 2026$198Mn/a$-1.90−$419M
June 30, 2026n/an/a$-3.06−$390M
March 31, 2026n/an/a$-2.29−$356M
December 31, 2025$0.00n/a$-1.89−$276M
September 30, 2025$0.00n/a$-1.61−$211M
June 30, 2025n/an/a$-1.31−$229M
March 31, 2025n/an/a$-1.13−$198M
December 31, 2024$0.00−100.0%$-1.13−$140M

Three-model forecasts for the next quarter

Written November 21, 2026, before the report. Each settles from the SEC filing.

17 ledger entries and 19 corporate events on record. Share price as of November 20, 2026. Research and education only. Not investment advice. Stoquity does not manage money or know your circumstances. Ratings, forecasts and lists are produced by software and AI models and can be wrong. Performance figures are hypothetical, measured on paper against a benchmark, and say nothing certain about the future.